ZEG Berlin GmbH
Zentrum für Epidemiologie und Gesundheitsforschung
Primary data can identify rare adverse outcomes and customize risk management plans. Our non-interventional and cohort studies go to the source - real people - to collect targeted and potentially sensitive data not always available on electronic databases. Assessing real use risks, we help to resolve safety concerns, validated by treating physicians.